LyondellBasell Industries N.V. (LYB) stock analysis
Close on Nov 11, 2026Market cap $20.23BP/E –Yield 8.71%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid15 of 30 checks passed
LyondellBasell Industries passes 15 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 3/6
- Growth
- 2/6
- Past performance
- 1/6
- Financial health
- 4/6
- Dividend
- 5/6
What stands out
Margin of safety over 20%
The price is 31.0% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $62.58 is below our fair value estimate of $90.68.
Return on capital over 10%
Return on invested capital was 11.1%, above the 10% that usually covers the cost of capital.
Interest well covered
Operating income covers interest expense 5.1 times.
What to watch
High debt
Debt is 110% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew -15.8% a year over the last three fiscal years, short of the 10% we look for.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.19; above 3 is the safe zone and below 1.8 the distress zone.
P/B above the industry
LyondellBasell Industries's price-to-book of 1.80 is above the Chemicals and Allied Products median of 1.51.
Valuation3/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA below its 5-year median
LyondellBasell Industries's EV/EBITDA of 6.5 is below its 5-year median of 8.4.
P/B above the industry
LyondellBasell Industries's price-to-book of 1.80 is above the Chemicals and Allied Products median of 1.51.
Trading below fair value
The share price of $62.58 is below our fair value estimate of $90.68.
Margin of safety over 20%
The price is 31.0% below fair value, more than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew -15.8% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 3.5% over the last twelve months; the Chemicals and Allied Products median is 3.5%.
Guidance raised
LyondellBasell Industries raised its third quarter operating rates for Intermediates & Derivatives assets outlook on Jul 31, 2026.
Gross margin improving
Gross margin was 14.3% over the last twelve months, against 9.9% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 11.1%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health4/6
High debt
Debt is 110% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 200% five years ago to 110%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 30.1% of total debt.
Interest well covered
Operating income covers interest expense 5.1 times.
Short-term assets cover short-term debts
Current assets are 1.78 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.19; above 3 is the safe zone and below 1.8 the distress zone.
Dividend5/6
Pays a dividend
LyondellBasell Industries paid dividends worth 5.5% of the share price over the last twelve months.
Yield above Treasuries
The 5.5% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; LyondellBasell Industries yields 5.5%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Covered by free cash flow
Dividends take 46.2% of free cash flow.
Fair value
How we estimate itOur estimate per share
$90.68
The share price is 31% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 9.4× | 8.4× | 10.4× | $100.88 | 58% |
| P/B | 1.9× | 2.3× | 1.5× | $65.91 | 17% |
| Earnings power | 8.1% cost of equity | – | – | $83.40 | 25% |
| Fair value | $90.68 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Chemicals and Allied Products median 25.2
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $229.42M
- Value traded per 1% price move
- $134.07M
Downside
Medium risk
- Typical loss in a bad month
- 18.9%
- Volatility (annualized)
- 43%
- Sharpe ratio, 1 year
- 0.98
- Beta to the S&P 500 (5Y)
- 0.65
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -9.7% | -15.8% | +1.7% | -0.8% | |
| Gross profit | -44.5% | -26.9% | -5.4% | -9.6% | |
| Free cash flow | -80.6% | -55.1% | -23.4% | -21.6% | |
| Dividend per share | +3.4% | +5.1% | +5.3% | +6.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 60.9% | – | – | |
| Return on assets | 16.6% | – | – | |
| Current ratio | 2.11 | 2.11 | 1.77 | |
| Debt to equity | 1.48 | 2.00 | 1.28 | |
| Net debt to EBITDA | 1.32× | 4.82× | 9.79× | |
| Interest coverage | 15.7× | 3.0× | -0.9× | |
| Inventory turnover | 5.9× | 5.5× | 6.7× | |
| Capex to revenue | 7.7% | 7.0% | 6.2% |
Where the cash went
Fiscal 2021 to 2025, five years combined
LyondellBasell Industries generated $24.84B from operations and spent $20.41B on capital expenditure, dividends and share buybacks. 45% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2019 | 9.8% | 1.18× | 3.21× | 37.1% |
| FY2018 | 12.0% | 1.43× | 2.84× | 48.8% |
| FY2017 | 14.1% | 1.39× | 3.31× | 65.1% |
| FY2016 | 13.1% | 1.26× | 3.67× | 60.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$2.26B
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$2.26B vs –
- Less leverageLong-term debt to assets fell29.5% → 35.7%
- Better liquidityCurrent ratio rose1.83 → 1.77
- No dilutionShare count did not rise– → –
- Gross margin improvedGross margin up on the prior year13.91% → 8.55%
- More efficientAsset turnover rose0.90 → 0.84
See a number that looks wrong?